Single-gene testing by Sanger sequencing is a cost-effective method for the study of inherited disorders with low phenotypic and genetic heterogeneity. However, as the levels of heterogeneity increase, it’s more efficient to use next-generation sequencing (NGS) panels to study multiple targets simultaneously.
Watch our latest webinar featuring case studies from King Faisal Hospital and Mount Sinai about the application of NGS panels to uncover disease causing variants for clinical research.
The Ion Chef and Ion GeneStudio S5 systems enable a simple, rapid and flexible targeted sequencing workflow.
Genexus System enables specimen-to-variant report NGS automation in a single day for inherited disease clinical research applications.
* Cloud-based Ion Reporter software can be accessed by all users free-of-charge until storage exceeds 100 GB, at which time a local server will be necessary.
Whether your research is focused on a single gene or more complex inherited disorders, Ion AmpliSeq™ technology offers a solution that fits your needs. Whether you choose a focused panel or require complete exome coverage, all panels deliver exceptional coverage (>90% on-target bases) and outstanding uniformity (typically >90% bases within 20% of the mean).
Ion AmpliSeq panels for inherited disease research enable researchers to survey across sets of genes that have been scientifically curated as the most prevalent genes for containing a candidate mutation based on criteria such as phenotype and disease. Research panels representing a wide range of inherited conditions, from cardiovascular to dermatological disease, are available.
Should a gene panel approach fail on first pass or simply not be appropriate to your research goal, the Ion AmpliSeq™ Exome RDY Panel offers an exhaustive search option, covering typically >97% of protein coding sequence.
Should none of these options fit your needs, customization of your own panel content using the online Ion AmpliSeq™ Designer tool is a snap.
Interested in detecting RNA expression changes?
Ion AmpliSeq RNA panels enable you to choose from over 20,000 targeted genes to survey gene expression fold changes starting with as little as 500 pg of unfixed RNA or 10 ng of formalin-fixed, paraffin-embedded (FFPE) RNA.
Research in the field of reproductive genomics is moving at an unprecedented pace. Harness the most rapid sequencing technology to accelerate aneuploidy detection in your clinical research lab.
The Ion ReproSeq PGS Kit offers detection of whole-chromosome and chromosome arm events (>48 Mb) from just 6 pg of embryonic DNA from a single cell.
Scalable targeted NGS to support small and large projects
The Ion GeneStudio S5 system is a scalable, targeted-NGS workhorse with wide application breadth and throughput capability.
Specimen to report in a single day with a hands-off, automated workflow*
The Genexus System is the first turnkey NGS solution that automates the specimen-to-report workflow and delivers results in a single day with just two user touchpoints.*
Ion Torrent™ technology has been cited in more than 2,000 publications since its introduction in 2011. The following application notes and case studies highlight how you can apply the Ion Torrent NGS solution to uncover the genetic basis of inherited disorders.
*Specimen-to-report workflow will be available after the Ion Torrent Genexus Purification System and integrated reporting capabilities are added in 2020.
For Research Use Only. Not for use in diagnostic procedures.